Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)

HKG:6609 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 3, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,574	837	1,135	1,417	4,070	-
Market Cap Growth	49.82%	-26.22%	-19.93%	-65.18%	-	-
Enterprise Value	838	99	378	299	3,477	-
Last Close Price	41.58	21.95	29.75	36.75	104.80	-
Forward PE	38.29	29.68	-	-	-	-
PS Ratio	4.29	2.83	4.43	6.85	36.80	-
PB Ratio	1.29	0.74	0.96	1.08	2.42	-
P/TBV Ratio	1.34	0.77	1.00	1.12	2.51	-
EV/Sales Ratio	2.28	0.33	1.48	1.45	31.45	-
Debt / Equity Ratio	0.04	0.03	0.03	0.04	0.03	0.04
Net Debt / Equity Ratio	-0.60	-0.64	-0.64	-0.70	-0.86	-0.88
Net Debt / EBITDA Ratio	-31.61	68.68	6.68	4.72	7.73	3.10
Net Debt / FCF Ratio	-22.00	93.21	7.36	2.70	4.55	6.72
Asset Turnover	0.27	0.23	0.19	0.13	0.08	0.03
Inventory Turnover	0.77	0.66	0.58	0.72	1.72	1.68
Quick Ratio	12.15	9.85	13.50	13.40	22.43	17.33
Current Ratio	15.45	12.42	16.82	16.77	24.05	18.08
Return on Equity (ROE)	3.89%	-1.27%	-8.39%	-15.79%	-19.18%	-56.00%
Return on Assets (ROA)	-0.01%	-1.73%	-6.31%	-8.86%	-8.76%	-29.08%
Return on Capital Employed (ROCE)	0.00%	-3.00%	-11.10%	-16.00%	-11.00%	-27.30%
Earnings Yield	2.95%	-1.73%	-9.13%	-15.99%	-5.86%	-
FCF Yield	2.13%	-0.92%	-9.03%	-24.20%	-7.80%	-
Buyback Yield / Dilution	-0.72%	0.81%	0.51%	-14.60%	-52.84%	-16.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.